{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:27:19Z","timestamp":1793766439455,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1NU58DP007156"],"award-info":[{"award-number":["1NU58DP007156"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005002","name":"California Department of Public Health","doi-asserted-by":"publisher","award":["California Health and Safety Code Section 103885"],"award-info":[{"award-number":["California Health and Safety Code Section 103885"]}],"id":[{"id":"10.13039\/100005002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261201800009I"],"award-info":[{"award-number":["HHSN261201800009I"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clgc.2026.102626","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:08:43Z","timestamp":1784304523000},"page":"102626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Type and Mortality for Black Versus White Patients With Muscle-Invasive Bladder Cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0559-7684","authenticated-orcid":false,"given":"Peyton A.","family":"Skupin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun","family":"Orikogbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Jordan","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy C.","family":"Obiora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Stencel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa N.","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Alameddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Yabes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clgc.2026.102626_bib0001","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clgc.2026.102626_bib0002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cncr.23986","article-title":"Sex and racial differences in bladder cancer presentation and mortality in the US","volume":"115","author":"Scosyrev","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2026.102626_bib0003","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/cam4.4917","article-title":"Racial inequity and other social disparities in the diagnosis and management of bladder cancer","volume":"12","author":"Hasan","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.clgc.2026.102626_bib0004","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.urology.2023.02.045","article-title":"Insurance type and area deprivation are associated with worse overall mortality for patients with muscle-invasive bladder cancer","volume":"177","author":"Miller","year":"2023","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.clgc.2026.102626_bib0005","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/cncr.31926","article-title":"Impact of tumor, treatment, and access on outcomes in bladder cancer: can equal access overcome race-based differences in survival?","volume":"125","author":"Cole","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2026.102626_bib0006","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.urology.2020.06.087","article-title":"Sex and racial disparities in the treatment and outcomes of muscle-invasive bladder cancer","volume":"151","author":"Marinaro","year":"2021","journal-title":"Urology"},{"issue":"22","key":"10.1016\/j.clgc.2026.102626_bib0007","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1002\/cam4.3429","article-title":"Race modifies survival benefit of guideline-based treatment: implications for reducing disparities in muscle invasive bladder cancer","volume":"9","author":"Washington","year":"2020","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.clgc.2026.102626_bib0008","doi-asserted-by":"crossref","first-page":"164.e17","DOI":"10.1016\/j.urolonc.2021.12.004","article-title":"Treatment disparities in muscle-invasive bladder cancer: evidence from a large statewide cancer registry","volume":"40","author":"Shah","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2026.102626_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.564779","article-title":"Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: a meta-analysis","volume":"10","author":"Ding","year":"2020","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.clgc.2026.102626_bib0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.clgc.2026.102626_bib0011","first-page":"755","article-title":"Population-based assessment of racial\/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer","volume":"28","author":"Williams","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"55","key":"10.1016\/j.clgc.2026.102626_bib0012","first-page":"3","article-title":"Updated overview of the SEER-Medicare data: enhanced content and applications","volume":"2020","author":"Enewold","year":"2020","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"12","key":"10.1016\/j.clgc.2026.102626_bib0013","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102626_bib0014","doi-asserted-by":"crossref","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","article-title":"Bladder Cancer, version 3.2024","volume":"22","author":"Flaig","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.clgc.2026.102626_bib0015","article-title":"Rstpm2: smooth parametric survival models","author":"Lambert","year":"2021","journal-title":"R"},{"key":"10.1016\/j.clgc.2026.102626_bib0016","first-page":"2","article-title":"A package for survival analysis","volume":"3","author":"Therneau","year":"2021","journal-title":"R"},{"key":"10.1016\/j.clgc.2026.102626_bib0017","first-page":"2","article-title":"cmprsk: subdistribution Analysis of competing risks","volume":"2","author":"Gray","year":"2022","journal-title":"R"},{"key":"10.1016\/j.clgc.2026.102626_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.564779","article-title":"Trimodal therapy vs. Radical cystectomy for muscle-invasive bladder cancer: a meta-analysis","volume":"10","author":"Ding","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.clgc.2026.102626_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.urology.2020.06.087","article-title":"Sex and racial disparities in the treatment and outcomes of muscle-invasive bladder cancer","volume":"151","author":"Marinaro","year":"2021","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.clgc.2026.102626_bib0020","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/cncr.31926","article-title":"Impact of tumor, treatment, and access on outcomes in bladder cancer: can equal access overcome race-based differences in survival?","volume":"125","author":"Cole","year":"2019","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.clgc.2026.102626_bib0021","doi-asserted-by":"crossref","first-page":"469.e1","DOI":"10.1016\/j.urolonc.2018.07.012","article-title":"Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: a national cancer database analysis","volume":"36","author":"Gild","year":"2018","journal-title":"Urol Oncol"},{"issue":"22","key":"10.1016\/j.clgc.2026.102626_bib0022","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1002\/cam4.3429","article-title":"Race modifies survival benefit of guideline-based treatment: implications for reducing disparities in muscle invasive bladder cancer","volume":"9","author":"Washington","year":"2020","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.clgc.2026.102626_bib0023","doi-asserted-by":"crossref","first-page":"343.e15","DOI":"10.1016\/j.urolonc.2022.02.008","article-title":"Disparities in patient and system factors explain racial\/ethnic disparities in delayed time to treatment in muscle invasive bladder cancer","volume":"40","author":"Buac","year":"2022","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102626_bib0024","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.urolonc.2020.02.013","article-title":"Inequity in selective referral to high-volume hospitals for genitourinary malignancies","volume":"38","author":"Berg","year":"2020","journal-title":"Urol Oncol"},{"issue":"7","key":"10.1016\/j.clgc.2026.102626_bib0025","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/cncr.28520","article-title":"Racial variation in the quality of surgical care for bladder cancer","volume":"120","author":"Barocas","year":"2014","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clgc.2026.102626_bib0026","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/cncr.22449","article-title":"Factors affecting outcomes after radical cystectomy in African Americans","volume":"109","author":"Konety","year":"2007","journal-title":"Cancer"},{"issue":"5S","key":"10.1016\/j.clgc.2026.102626_bib0027","doi-asserted-by":"crossref","DOI":"10.1097\/01.JU.0001008796.84999.75.13","article-title":"MP70-13\u2003Factors that define the poor outcomes for black Americans with bladder cancer: does time to treatment contribute?","volume":"211","author":"Orikogbo","year":"2024","journal-title":"Journal of Urology"},{"issue":"12","key":"10.1016\/j.clgc.2026.102626_bib0028","doi-asserted-by":"crossref","first-page":"834.e9","DOI":"10.1016\/j.urolonc.2021.04.030","article-title":"The centralization of bladder cancer care and its implications for patient travel distance","volume":"39","author":"Pekala","year":"2021","journal-title":"Urol Oncol"},{"issue":"7","key":"10.1016\/j.clgc.2026.102626_bib0029","doi-asserted-by":"crossref","first-page":"343.e15","DOI":"10.1016\/j.urolonc.2022.02.008","article-title":"Disparities in patient and system factors explain racial\/ethnic disparities in delayed time to treatment in muscle invasive bladder cancer","volume":"40","author":"Buac","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2026.102626_bib0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canep.2016.04.012","article-title":"Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system","volume":"42","author":"Schinkel","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clgc.2026.102626_bib0031","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.urology.2020.12.020","article-title":"Social and clinical correlates of neoadjuvant chemotherapy in Medicare beneficiaries with muscle invasive bladder cancer from 2004 to 2015","volume":"149","author":"Nyame","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2026.102626_bib0032","doi-asserted-by":"crossref","DOI":"10.1177\/10732748231152322","article-title":"Impact of age at diagnosis of bladder cancer on survival: a surveillance, epidemiology, and end results-based study 2004-2015","volume":"30","author":"Lin","year":"2023","journal-title":"Cancer Control"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:15:26Z","timestamp":1793765726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326001266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1558767326001266"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102626","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Type and Mortality for Black Versus White Patients With Muscle-Invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102626"}}